Cargando…
Control of Helicobacter pylori with engineered probiotics secreting selective guided antimicrobial peptides
Helicobacter pylori is the primary cause of 78% of gastric cancer cases, providing an opportunity to prevent cancer by controlling a single bacterial pathogen within the complex gastric microbiota. We developed highly selective antimicrobial agents against H. pylori by fusing an H. pylori-binding gu...
Autores principales: | Choudhury, Ankan, Ortiz, Patrick S., Young, Mikaeel, Mahmud, Md. Toslim, Stoffel, Ryan T., Greathouse, K. Leigh, Kearney, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580918/ https://www.ncbi.nlm.nih.gov/pubmed/37712669 http://dx.doi.org/10.1128/spectrum.02014-23 |
Ejemplares similares
-
Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight
por: Greathouse, K. Leigh, et al.
Publicado: (2021) -
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori
por: Saracino, Ilaria Maria, et al.
Publicado: (2020) -
Helicobacter pylori treatment: antibiotics or probiotics
por: Goderska, Kamila, et al.
Publicado: (2017) -
Role of Probiotics in the Management of Helicobacter pylori
por: Mestre, Andrea, et al.
Publicado: (2022) -
The impacts of probiotics in eradication therapy of Helicobacter pylori
por: Bai, Xiaofen, et al.
Publicado: (2022)